Letter to the Editor: Discussion on the suicide risk of CCB drugs: based on real-world drug safety surveillance

被引:0
|
作者
Luo, Dongqiang [1 ]
Wu, Jiayu [2 ]
Liu, Bingshuo [3 ]
机构
[1] Guangzhou Univ Chinese Med, Clifford Hosp, Guangzhou, Peoples R China
[2] Guangzhou Univ Chinese Med, Clin Coll 1, Guangzhou, Peoples R China
[3] Guangzhou Univ Chinese Med, Sch Clin Med 5, Guangzhou, Peoples R China
关键词
SIGNAL; SYSTEMS;
D O I
10.1017/S003329172400254X
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:4930 / 4932
页数:3
相关论文
共 50 条
  • [41] Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
    Chan, Kelvin
    Nam, Seungree
    Evans, Bill
    de Oliveira, Claire
    Chambers, Alexandra
    Gavura, Scott
    Hoch, Jeffrey
    Mercer, Rebecca E.
    Dai, Wei Fang
    Beca, Jaclyn
    Tadrous, Mina
    Isaranuwatchai, Wanrudee
    BMJ OPEN, 2020, 10 (01):
  • [42] Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database
    Wu, Junlin
    Wu, Hanbiao
    Chen, Lili
    Liang, Haiping
    Huang, Guoning
    Yang, Sensen
    Chen, Bishan
    Noguchi, Yoshihiro
    Shen, Yonggang
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (07) : 905 - 916
  • [43] Clinical safety evaluation of contrast agents based on real-world evidence
    Jiang, Cheng
    Li, Junlian
    Huang, Yaoqin
    Huang, Daiying
    Lin, Jingran
    Jiang, Xin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (06) : 1600 - 1605
  • [44] A Discussion of Data Requirements and Methodologic Considerations for Evaluating the Real-World Effectiveness and Safety of Biosimilar Medicines
    Kugener, Veronique
    Kelsh, Michael
    Bradbury, Brian
    Giezen, Thijs
    Bosco, Jaclyn
    Trifiro, Gianluca
    Golembesky, Amanda
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 281 - 282
  • [45] Response to letter to the editor: "Risk factors for suicide in patients with colorectal cancer: a Surveillance, Epidemiology, and End Results database analysis"
    Dourado, Justin
    Emile, Sameh Hany
    Wexner, Steven D.
    SURGERY, 2025, 180
  • [46] Are drug safety measures harmonized? A real-world evidence from three regulatory authorities
    Alelayan, Sadeem
    Al-Sheikh, Leena
    Almotawa, Rana
    Alkofide, Hadeel
    Alshammari, Thamir
    SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (03)
  • [47] Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study
    Weersink, Rianne A.
    Taxis, Katja
    Drenth, Joost P. H.
    Houben, Eline
    Metselaar, Herold J.
    Borgsteede, Sander D.
    DRUG SAFETY, 2019, 42 (04) : 539 - 546
  • [48] Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study
    Crisafulli, Salvatore
    Sultana, Janet
    Ingrasciotta, Ylenia
    Addis, Antonio
    Cananzi, Pasquale
    Cavagna, Lorenzo
    Conter, Valentino
    D'Angelo, Gabriella
    Ferrajolo, Carmen
    Mantovani, Lorenzo
    Pastorello, Maurizio
    Scondotto, Salvatore
    Trifiro, Gianluca
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (06) : 497 - 509
  • [49] Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study
    Rianne A. Weersink
    Katja Taxis
    Joost P. H. Drenth
    Eline Houben
    Herold J. Metselaar
    Sander D. Borgsteede
    Drug Safety, 2019, 42 : 539 - 546
  • [50] Safety, Efficacy, and Drug Survival of Colchicine in Recurrent Aphthous Stomatitis in a Real-World Setting
    Oh, Jongwook
    Lee, Jae-Won
    Chung, Kyung Bae
    Bang, Dongsik
    Kim, Do-Young
    ANNALS OF DERMATOLOGY, 2022, 34 (01) : 22 - 27